REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr.Max Namesti Republiky A.S. (Czech Republic)

Main Activities: Pharmacies and Drug Stores | Department Stores
Full name: Dr.Max Namesti Republiky A.S. Profile Updated: October 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Dr.Max Namesti Republiky A.S. is an enterprise located in Czech Republic, with the main office in Brno. The enterprise operates in the Pharmacies and Drug Stores industry. It was first established on September 19, 2003. It currently has a total number of 20 - 24 (2026) employees. The company’s latest financial report indicates a net sales revenue drop of 5.31% in 2025. During that time, Dr.Max Namesti Republiky A.S.’s total assets grew by 1.17%. In 2025, Dr.Max Namesti Republiky A.S.’s net profit margin decreased by 0.85%.

Headquarters
Nove sady 996/25
Brno; Jihomoravsky; Postal Code: 60200

Contact Details: Purchase the Dr.Max Namesti Republiky A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Dr.Max Namesti Republiky A.S. report to view the information.
Registered Capital:
Purchase the Dr.Max Namesti Republiky A.S. report to view the information.
Financial Auditors:
Purchase the Dr.Max Namesti Republiky A.S. report to view the information.
Incorporation Date:
September 19, 2003
Key Executives
Purchase this report to view the information.
Administrative Manager
Purchase this report to view the information.
Administrative Manager
Company Performance
Financial values in the chart are available after Dr.Max Namesti Republiky A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-5.31%▼
Total Operating Revenue
-3.56%▼
Operating Profit
-29.63%▼
EBITDA
-33.57%▼
Net Profit/Loss for the Period
-42.77%▼
Total Assets
1.17%▲
Total Equity
-17.02%▼
Operating Profit Margin
-0.99%▼
Net Profit Margin
-0.85%▼
Return on Equity (ROE)
-12.7%▼
Debt / Equity
40.54%▲
Quick Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?